Actively Recruiting
Study on Tolerability When Switching From Tirzepatide to Zenagamtide in Adults With Overweight or Obesity, With or Without Type 2 Diabetes
Led by Novo Nordisk A/S · Updated on 2026-10-16
60
Participants Needed
2
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying adults with overweight or obesity, with or without type 2 diabetes, to understand how they tolerate switching from their current medication, tirzepatide, to a new treatment called zenagamtide. This Phase 1, open-label trial aims to find which dose of zenagamtide participants can switch to after maintenance treatment with tirzepatide. Participants in this study all currently use tirzepatide and will be evaluated for safety and tolerability during the switch. Participants will first receive tirzepatide once weekly by subcutaneous injection using pre-filled pen-injectors applied to the thigh, abdomen, or upper arm. After completing their last maintenance dose of tirzepatide, they will switch to one of several dose levels of zenagamtide, also given once weekly by subcutaneous injection with a similar pen-injector device. This sequential dosing approach allows researchers to monitor how participants respond to the new medication after stopping tirzepatide. Throughout the study, participants will be monitored for any treatment-emergent adverse events from the first dose of zenagamtide up to 57 days. Researchers will also measure zenagamtide levels in the blood to understand how the drug is processed in the body. Vital signs, electrocardiograms, clinical laboratory tests, and medical history evaluations will help assess safety. The trial is expected to last until September 2028, with all study visits and treatments provided under medical supervision.
CONDITIONS
Brief Title
A Research Study Investigating How Adults With Overweight or Obesity, With or Without Type 2 Diabetes, Tolerate Switching to a New Treatment (Zenagamtide) From Their Current Tirzepatide Medication
Research Team
N
Novo Nordisk
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here